Takeda 12-Month Price Target Raised to $20.74
The 12-month price target for Takeda Pharmaceutical Company Limited was raised to $20.74, implying 9% upside.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.